Johnson Controls Launches Integrated Laboratory Services
Johnson Controls launches Integrated Laboratory Services for R&D facility operations and scientific productivity.
Johnson Controls announced an improved Integrated Laboratory Services (ILS) for the life-sciences market at Pittcon 2014, which includes a range of specialist solutions to help customers increase operational and financial efficiencies and manage risk within their R&D, manufacturing, data center, HQ, and warehousing facilities.
Johnson Controls is responsible for delivering IFM & lab services and supporting quality and compliance for 100 million ft2 of life-science facilities globally, with 40% of those facilities being regulated space.
The life-sciences team has developed a new scientific asset visualization tool, a reporting and analytics tool that enables data-driven decisions and delivers improved lab functions through dashboards and reports, interpreting various data sources, and utilizing its global data warehouse for Integrated Laboratory Services.
Source: Johnson Controls
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
